Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Solid Biosciences (SLDB) Return on Capital Employed (2018 - 2024)

Solid Biosciences (SLDB) has disclosed Return on Capital Employed for 7 consecutive years, with 0.56% as the latest value for Q3 2024.

  • Quarterly Return on Capital Employed rose 9.0% to 0.56% in Q3 2024 from the year-ago period, while the trailing twelve-month figure was 0.56% through Sep 2024, up 9.0% year-over-year, with the annual reading at 0.53% for FY2023, 5.0% down from the prior year.
  • Return on Capital Employed hit 0.56% in Q3 2024 for Solid Biosciences, down from 0.44% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.31% in Q2 2021 to a low of 2.88% in Q3 2020.
  • Historically, Return on Capital Employed has averaged 0.77% across 5 years, with a median of 0.51% in 2024.
  • Biggest five-year swings in Return on Capital Employed: plummeted -175bps in 2020 and later skyrocketed 256bps in 2021.
  • Year by year, Return on Capital Employed stood at 1.09% in 2020, then surged by 69bps to 0.33% in 2021, then crashed by -60bps to 0.53% in 2022, then fell by -22bps to 0.65% in 2023, then increased by 13bps to 0.56% in 2024.
  • Business Quant data shows Return on Capital Employed for SLDB at 0.56% in Q3 2024, 0.44% in Q2 2024, and 0.51% in Q1 2024.